B. Current evidence from a large case-control analysis found no significant protective effect of first-trimester folic acid use on congenital heart anomalies in infants with Down syndrome (adjusted OR 0.95, 95 % CI 0.61–1.47) [Meijer et al., 2006, PMID 17051586].